State Bank of India is down for a fifth straight session today. The stock is quoting at Rs 818.75, down 1.69% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is down around 0.93% on the day, quoting at 23729.80078125. The Sensex is at 78412.16, down 1.02%.State Bank of India has added around 4.87% in last one month.Meanwhile, Nifty Bank index of which State Bank of India is a constituent, has increased around 1.52% in last one month and is currently quoting at 51575.7, down 0.85% on the day. The volume in the stock stood at 41.27 lakh shares today, compared to the daily average of 118.68 lakh shares in last one month. The benchmark December futures contract for the stock is quoting at Rs 821.4, down 1.61% on the day. State Bank of India jumped 27.18% in last one year as compared to a 11.64% rally in NIFTY and a 6.89% spurt in the Nifty Bank index.The PE of the stock is 10.56 based on TTM earnings ending September 24.Powered by Capital Market - Live

Rama Mohan Rao Amara was holding the position of 'deputy managing director & chief risk officer' of SBI until his appointment as MD. Further, Kshitij Mohan, deputy managing director (SARG), has been given the additional charge of deputy MD & group chief risk officer, effective from 18 December 2024 as well. State Bank of India (SBI) is an Indian multinational, public sector banking, and financial services statutory body. As of 30 September 2024, the Government of India held a 57.51% stake in the bank. The largest PSU bank's standalone net profit rose 27.92% to Rs 18,331.44 crore on 15.13% increase in total income to Rs 129,141.11 crore in Q2 FY25 over Q2 FY24. The scrip shed 0.88% to currently trade at Rs 831.70 on the BSE.Powered by Capital Market - Live

The key domestic benchmarks traded with significant losses in morning trade, mirroring the negative sentiment in the global markets after the US Federal Reserve's interest rate decision. The Nifty traded below the 24,000 level. Metal shares witnessed selling pressure for the fifth consecutive trading session. At 10:29 IST, the barometer index, the S&P BSE Sensex, tumbled 880.41 points or 1.10% to 79,301.79. The Nifty 50 index dropped 247.25 points or 1.02% to 23,951.60. The broader market underperformed the frontline indices. The S&P BSE Mid-Cap index slipped 0.75% and the S&P BSE Small-Cap index fell 0.79%. The market breadth was weak. On the BSE, 1,186 shares rose and 2,463 shares fell. A total of 156 shares were unchanged. New Listing: Shares of Inventurus Knowledge Solutions were currently trading at Rs 1,861.35 at 10:15 IST on the BSE, representing a premium of 40.06% as compared with the issue price of Rs 1,329. The scrip was listed at Rs 1,856, exhibiting a premium of 39.65% to the issue price. So far, the stock has hit a high of 1,942.10 and a low of 1856. On the BSE, over 4.73 lakh shares of the company were traded in the counter so far. Buzzing Index: The Nifty Metal index dropped 1.73% to 8,913.20. The index fell 6.25% in five consecutive trading sessions. Vedanta (down 2.38%), Hindustan Copper (down 2.12%), National Aluminium Company (down 2.06%), Jindal Steel & Power (down 1.96%), Tata Steel (down 1.94%), Hindustan Zinc (down 1.78%), Jindal Stainless (down 1.78%), JSW Steel (down 1.74%), Hindalco Industries (down 1.63%) and Welspun Corp (down 1.59%) declined. Stocks in Spotlight: State Bank of India declined 1.20%. The bank's board has appointed Rama Mohan Rao Amara as managing director for three years. Meanwhile, Kshitij Mohan, deputy managing director (SARG) has been entrusted with additional charge of deputy managing director & group chief risk officer with effect from 18 December 2024. Borosil Renewables slipped 2.97%. The company's board has decided to withdraw its proposed right issue of an amount not exceeding Rs 450 crore and approved the proposal to raise Rs 600 crore through the preferential issue of equity shares and Rs 100 crore through warrants. Lupin added 0.45%. The company announced that it has received an approval from the United States Food and Drug Administration (U.S. FDA) for its abbreviated new drug application (ANDA) for Emtricitabine and Tenofovir Alafenamide Tablets. Emtricitabine and tenofovir alafenamide combination is used together with other medicines to treat human immunodeficiency virus (HIV) infection. HIV is the virus that causes acquired immune deficiency syndrome (AIDS). This medicine is also used for pre-exposure prophylaxis (PrEP) to reduce the risk of HIV-1 infection. Powered by Capital Market - Live

State Bank of India raised Rs 50,000 crore domestic bonds in FY 2025. The Bank raises Rs 5,000 crore AT1 Bonds, Rs 15,000crore Tier 2 Bonds and Rs 30,000 crore Long Term Bonds till date during FY25 at very competitive rate. All these issues have attracted overwhelming response from investors and were oversubscribed by more than 2 times against the respective base issue size. The investors were across provident funds, pension funds, insurance companies, mutual funds, Banks etc. Bank's AT1 Bonds are rated AA+ (stable outlook) and both the Tier 2 and Long Term Bonds are rated AAA (stable outlook). These bonds are of 15 years tenor except for the AT1 Bonds which is perpetual. The AT1 and Tier 2 Bonds raised by the Bank during the year are issued with call option after 10 years or any anniversary date thereafter.Powered by Capital Market - Live

State Bank of India has allotted 10,00,000 Non-convertible, Taxable, Redeemable, Unsecured, Fully Paid-up Long-Term Bonds in the nature of debentures of face value Rs.1 lakh each at a coupon of 7.23% aggregating Rs 10,000 crore on 19 November 2024. Powered by Capital Market - Live

State Bank of India (SBI) raised Rs 10,000 crore today at a coupon rate of 7.23% through its seventh infrastructure bond issuance. The issue attracted overwhelming response from investors with bids in excess of Rs 11,500 crore and was oversubscribed in excess of 2 times against the base issue size of Rs 5,000 crore. The total number of bids received was 85 indicating wider participation with heterogeneity of bids. The investors were across provident funds, pension funds, insurance companies, mutual funds etc. The proceeds of bonds will be utilized in enhancing long term resources for funding infrastructure and affordable housing segment. Based on the response, the Bank has decided to accept Rs 10,000 crore at a coupon rate of 7.23% payable annually for a tenor of 15 years. The instrument is rated AAA with stable outlook. Powered by Capital Market - Live

The Nifty November 2024 futures closed at 24,196.40, a premium of 48.20 points compared with the Nifty's closing 24,148.20 in the cash market. In the cash market, the Nifty 50 lost 51.15 points or 0.21% to 24,148.20. The NSE's India VIX, a gauge of market's expectation of volatility over the near term, fell 2.45% to 14.57. State Bank of India, Reliance Industries and Mahindra & Mahindra were the top traded individual stock futures contracts in F&O segment of NSE. The November 2024 F&O contracts will expire on 28 November 2024. Powered by Capital Market - Live

Net profit of State Bank of India rose 22.88% to Rs 19782.76 crore in the quarter ended September 2024 as against Rs 16099.58 crore during the previous quarter ended September 2023. Total Operating Income rose 12.71% to Rs 121044.68 crore in the quarter ended September 2024 as against Rs 107390.78 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Total Operating Income121044.68107390.78 13 OPM %48.1944.72 - PBDT27474.3121935.71 25 PBT27474.3121935.71 25 NP19782.7616099.58 23 Powered by Capital Market - Live

Profit before tax in second quarter of FY25 stood at Rs 24,788.01 crore, registering a growth of 28.43% on YoY basis. Net interest income rose 5.37% YoY to Rs 41,620 crore in September 2024 quarter. Net interest margin (domestic) reduced by 16 bps to 3.27% in Q2 FY25 as against 3.43% in Q2 FY24. Operating profit climbed 50.87% to Rs 29,294 crore in Q2 of FY25 as compared with Rs 19,417 crore posted in corresponding quarter last year. Total deposits grew 9.13% to Rs 51,17,285 crore as on 30 September 2024 as against Rs 46,89,218 crore as on 30 September 2023, out of which CASA Deposit grew by 4.24% YoY. CASA ratio slipped 185 bps to 40.03% as on September 2024. The bank's return on assets (ROA) for the quarter stood at 1.17% as against 1.01% in Q2 FY24. Provision coverage ratio (PCR) improved by 21 bps YoY to 75.66%. PCR (including AUCA) stood at 92.21%, up 28 bps YoY. The bank's gross non-performing assets (NPAs) slipped to Rs 83,369.23 crore as on 30 September 2024 as against Rs 86,974.08 crore as on 30 September 2023. The ratio of gross NPAs to gross advances stood at 2.13% as on September 2024 as against 2.55% as on September 2023. The ratio of net NPAs to net advances stood at 0.53% as on 30 September 2024 as against 0.64% as on 30 September 2023. The bank's credit growth stood at 14.93% YoY with domestic advances growing at 15.55% YoY and foreign offices' advances rose by 11.56% YoY. Capital Adequacy Ratio (CAR) as at the end of Q2 FY25 reduced by 52 bps YoY and stands at 13.76%, slippage ratio was at 0.51%, up by 5 bps YoY while credit cost rose 16 bps to 0.38%. State Bank of India (SBI) is an Indian multinational, public sector banking and financial services statutory body. As of 30 September 2024, the Government of India held 57.51% stake in the bank. The scrip declined 2.24% to currently trade at Rs 840 on the BSE.Powered by Capital Market - Live

The Board of State Bank of India at its meeting held on 08 November 2024 has accorded approval for raising Long Term Bonds up to an amount of Rs 20,000 crore through a public issue or private placement, during FY 25. Powered by Capital Market - Live